Merck & Co., Inc. operates as a global healthcare company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. Keytruda is its leading oncology treatment.
Merck & Co., Inc. operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for MRK.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). MRK Stock Intelligence Report. [stoxpulse.com/stocks/mrk]
Disclaimer: The information on this page about Merck & Co., Inc. (MRK) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Merck & Co., Inc..
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 52%
Jun 30
Guindo sold 10K shares
Aug 13
Zachary bought 41K shares
Aug 12
Nike: Just Not Doing It
6h ago
Merck (MRK) Sees a More Significant Dip Than Broad...
8h ago
StoxPulse AI results for MRK: Pulse Score 44.5/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$370.89B
P/E Ratio
20.6
EPS
$-0.54
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sep 25
+13.1%
Dec 25
+3.0%
Mar 26
+16.0%
Jun 26
+52.3%
Beat estimates 4 of 4 quarters (100%)
Merck & Co., Inc. operates as a global healthcare company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. Keytruda is its leading oncology treatment.
Nike: Just Not Doing It
Merck (MRK) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Which dow jones stocks are moving on Friday?
Could Merck (MRK) Change Cholesterol Treatment With The First Oral PCSK9 Pill?
Was JNJ Stock Rally Actually Its Own?
SMMT Stock Soars on NSCLC Drug Survival Data Beating Keytruda in China
Wells Fargo Maintains Overweight on Merck & Co, Raises Price Target to $170
Merck's $8.4 Billion Keytruda Fortress Gets a 2028 Warning